Yunlong Wang
Yunlong Wang
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The COMBINE-AF Trial | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Not yet recruiting | Not applicable | 2026-07-27 | NCT07633509 | |
| Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients | Arrhythmias, Cardiac, Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Phase 4 | 2026-07-21 | NCT07715929 | |
| Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF | Arrhythmias, Cardiac, Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Phase 4 | 2026-06-05 | NCT07630454 |